---
title: "AMIN NASEEM — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0beb5463-ce08-5a32-ae76-eab5c975c36a
json: https://whiteintel.dev/api/public/dossier/0beb5463-ce08-5a32-ae76-eab5c975c36a
identifier: sec:0001646754
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# AMIN NASEEM

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001646754`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/0beb5463-ce08-5a32-ae76-eab5c975c36a  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0beb5463-ce08-5a32-ae76-eab5c975c36a  

## Ownership & control

### Holdings / subsidiaries

- **AVADEL PHARMACEUTICALS PLC** (director) — https://whiteintel.dev/entity/36b7ec7b-c280-5d0c-961b-2a44499dc3fd
- **BELLEROPHON THERAPEUTICS LLC** (director) — https://whiteintel.dev/entity/312fbbb3-d819-59dd-89ca-335115384f70

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **AMIN NASEEM**. Human view: https://whiteintel.dev/entity/0beb5463-ce08-5a32-ae76-eab5c975c36a · Structured JSON: https://whiteintel.dev/api/public/dossier/0beb5463-ce08-5a32-ae76-eab5c975c36a._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._